$81.52
0.87%
Nasdaq, Sep 25, 04:00 pm EDT. Closed.

LeMaitre Vascular, Inc. Target price 2026 - Analyst rating & recommendation

LeMaitre Vascular, Inc. Classifications & Recommendation

Buy
64%
Hold
36%

LeMaitre Vascular, Inc. Price Target

Target Price $102.00
Price $81.52
Potential
Number of Estimates 9
9 Analysts have issued a price target LeMaitre Vascular, Inc. 2027 . The average LeMaitre Vascular, Inc. target price is $102.00. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 14 analysts: 9 Analysts recommend LeMaitre Vascular, Inc. to buy, 5 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the LeMaitre Vascular, Inc. stock has an average upside potential 2027 of . Most analysts recommend the LeMaitre Vascular, Inc. stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2032

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Revenue Million $ 249.60 282.07
13.53% 13.01%
EBITDA Margin 29.47% 32.85%
11.64% 11.46%
Net Margin 23.13% 23.80%
15.47% 2.90%

10 Analysts have issued a sales forecast LeMaitre Vascular, Inc. 2026 . The average LeMaitre Vascular, Inc. sales estimate is

$282m
unlock
. This is
7.48% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$291m 10.95%
unlock
, the lowest is
$270m 3.07%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 $250m 13.53%
2026
$282m 13.01%
unlock
2027
$309m 9.54%
unlock
2028
$334m 8.11%
unlock
2029
$357m 6.97%
unlock
2030
$401m 12.30%
unlock
2031
$437m 9.00%
unlock
2032
$477m 9.00%
unlock

9 Analysts have issued an LeMaitre Vascular, Inc. EBITDA forecast 2026. The average LeMaitre Vascular, Inc. EBITDA estimate is

$92.7m
unlock
. This is
11.73% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$101m 22.00%
unlock
, the lowest is
$85.1m 2.56%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $73.6m 26.74%
2026
$92.7m 25.98%
unlock
2027
$104m 12.26%
unlock
2028
$112m 7.87%
unlock
2029
$125m 11.17%
unlock

EBITDA Margin

2025 29.47% 11.64%
2026
32.85% 11.46%
unlock
2027
33.67% 2.50%
unlock
2028
33.59% 0.24%
unlock

10 LeMaitre Vascular, Inc. Analysts have issued a net profit forecast 2026. The average LeMaitre Vascular, Inc. net profit estimate is

$67.1m
unlock
. This is
2.21% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$69.6m 6.00%
unlock
, the lowest is
$63.6m 3.12%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $57.7m 31.09%
2026
$67.1m 16.27%
unlock
2027
$74.1m 10.43%
unlock
2028
$79.6m 7.35%
unlock
2029
$86.5m 8.72%
unlock

Net Margin

2025 23.13% 15.47%
2026
23.80% 2.90%
unlock
2027
23.99% 0.80%
unlock
2028
23.82% 0.71%
unlock
2029
24.21% 1.64%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2032

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share $ 2.52 2.94
30.57% 16.67%
P/E 27.76
EV/Sales 5.88

10 Analysts have issued a LeMaitre Vascular, Inc. forecast for earnings per share. The average LeMaitre Vascular, Inc. EPS is

$2.94
unlock
. This is
10.11% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$3.05 14.23%
unlock
, the lowest is
$2.78 4.12%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $2.52 30.57%
2026
$2.94 16.67%
unlock
2027
$3.24 10.20%
unlock
2028
$3.48 7.41%
unlock
2029
$3.78 8.62%
unlock

P/E ratio

Current 30.53 31.82%
2026
27.76 9.08%
unlock
2027
25.14 9.44%
unlock
2028
23.42 6.84%
unlock
2029
21.54 8.03%
unlock

Based on analysts' sales estimates for 2026, the LeMaitre Vascular, Inc. stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 6.31 23.61%
2026
5.88 6.89%
unlock
2027
5.36 8.71%
unlock
2028
4.96 7.50%
unlock
2029
4.64 6.51%
unlock
2030
4.13 10.95%
unlock
2031
3.79 8.26%
unlock
2032
3.48 8.26%
unlock

P/S ratio

Current 7.10 20.18%
2026
6.61 6.96%
unlock
2027
6.03 8.71%
unlock
2028
5.58 7.50%
unlock
2029
5.22 6.51%
unlock
2030
4.65 10.96%
unlock
2031
4.26 8.26%
unlock
2032
3.91 8.26%
unlock

Current LeMaitre Vascular, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Wells Fargo
Locked
➜
Locked
Locked Aug 05 2026
Barrington Research
Locked
➜
Locked
Locked Jun 03 2026
Barrington Research
Locked
➜
Locked
Locked May 06 2026
Citizens
Locked
➜
Locked
Locked May 06 2026
Wells Fargo
Locked
➜
Locked
Locked May 06 2026
Barrington Research
Locked
➜
Locked
Locked Feb 26 2026
Citizens
Locked
➜
Locked
Locked Feb 26 2026
Analyst Rating Date
Locked
Wells Fargo:
Locked
➜
Locked
Aug 05 2026
Locked
Barrington Research:
Locked
➜
Locked
Jun 03 2026
Locked
Barrington Research:
Locked
➜
Locked
May 06 2026
Locked
Citizens:
Locked
➜
Locked
May 06 2026
Locked
Wells Fargo:
Locked
➜
Locked
May 06 2026
Locked
Barrington Research:
Locked
➜
Locked
Feb 26 2026
Locked
Citizens:
Locked
➜
Locked
Feb 26 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today